KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Gains from Sales and Divestitures (2016 - 2017)

Idexx Laboratories (IDXX) has 7 years of Gains from Sales and Divestitures data on record, last reported at $155000.0 in Q4 2017.

  • For Q4 2017, Gains from Sales and Divestitures fell 8.82% year-over-year to $155000.0; the TTM value through Dec 2017 reached $155000.0, down 8.82%, while the annual FY2017 figure was $155000.0, 8.82% down from the prior year.
  • Gains from Sales and Divestitures reached $155000.0 in Q4 2017 per IDXX's latest filing, down from $170000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $196000.0 in Q4 2015 and bottomed at $122000.0 in Q4 2014.
  • Average Gains from Sales and Divestitures over 5 years is $156400.0, with a median of $155000.0 recorded in 2017.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 60.66% in 2015, then fell 13.27% in 2016.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $139000.0 in 2013, then decreased by 12.23% to $122000.0 in 2014, then surged by 60.66% to $196000.0 in 2015, then fell by 13.27% to $170000.0 in 2016, then dropped by 8.82% to $155000.0 in 2017.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $155000.0 in Q4 2017, $170000.0 in Q4 2016, and $196000.0 in Q4 2015.